Publications

European journal of cancer (Oxford, England : 1990)

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

25-06-2026

Journal of medical genetics

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

25-06-2026

NPJ breast cancer

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

25-06-2026

Behavioral medicine (Washington, D.C.)

Factors Associated with Healthcare Providers' Lifestyle Information Provision to Adult Patients in Oncology: A Systematic Literature Review.

24-06-2026

Nature communications

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

24-06-2026

Current oncology (Toronto, Ont.)

Coping with an Uncertain or Poor Cancer Prognosis as an Adolescent or Young Adult: A Cross-Sectional Cluster Analysis.

23-06-2026

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Stakeholder Perspectives on Potential Open-Label Bias in Patient-Reported Outcome Results From Cancer Clinical Trials: Evidence From the IMPROvE Project.

23-06-2026

European journal of cancer (Oxford, England : 1990)

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

18-06-2026

European journal of cancer (Oxford, England : 1990)

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

18-06-2026

Journal of the National Cancer Institute

Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysis.

18-06-2026

The Lancet. Oncology

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

17-06-2026

Nature communications

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

17-06-2026

European urology

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

17-06-2026

International journal of cancer

Toward a validated European instrument to measure the socioeconomic impact of cancer.

15-06-2026

Journal of the National Cancer Institute

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

12-06-2026

Nature communications

Towards robust foundation models for digital pathology.

11-06-2026

Pharmacogenomics

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

10-06-2026

BMJ open

Effect of yoga on musculoskeletal complaints in women during endocrine treatment for breast cancer: protocol of the randomised controlled COBRA trial.

09-06-2026

Journal of the National Cancer Institute

Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses.

05-06-2026

BJC reports

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

03-06-2026

American journal of physical medicine & rehabilitation

Assessing Cardiorespiratory Fitness in Clinical Rehabilitation: Validity of Field Exercise Tests and Patient-Reported Questionnaires.

02-06-2026

Journal of cancer survivorship : research and practice

Patient-reported outcomes in cancer survivorship: insights from two decades of population-based PROFILES registry research.

01-06-2026

European urology oncology

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

01-06-2026

European journal of nuclear medicine and molecular imaging

3D intraabdominal molecular imaging of primary prostate cancer, a hybrid approach that utilizes the robotic vision and dexterity.

01-06-2026

Life science alliance

Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

01-06-2026

Journal of cancer survivorship : research and practice

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

01-06-2026

European journal of nuclear medicine and molecular imaging

Flexible intraoperative detectors for robotic and laparoscopic image-guided surgery: a systematic review.

01-06-2026

British journal of clinical pharmacology

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

01-06-2026

Breast (Edinburgh, Scotland)

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

01-06-2026

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

01-06-2026

Mechanisms of ageing and development

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta_1-42-induced neurodegeneration.

01-06-2026

JAMA oncology

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis.

01-06-2026

British journal of clinical pharmacology

Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.

01-06-2026

JCO precision oncology

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

01-06-2026

British journal of cancer

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

01-06-2026

Cancer treatment reviews

Progress toward personalized management of stage II/III triple negative breast cancer.

01-06-2026

Cell research

Social status impacts T-cell responses through synapse strength in the prefrontal cortex.

01-06-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity.

01-06-2026

Cancer treatment reviews

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

01-06-2026

The Annals of otology, rhinology, and laryngology

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

01-06-2026

Journal of cancer survivorship : research and practice

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

01-06-2026

ESMO real world data and digital oncology

Validating large language model-assisted data extraction from clinical notes.

01-06-2026

PloS one

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

01-06-2026

Academic radiology

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

01-06-2026

Nature

Pervasive and programmed nucleosome distortion on single chromatin fibres.

01-06-2026

Cancer discovery

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

01-06-2026

Genes & development

Cohesin-mediated loop extrusion and enhancer-associated factors additively contribute to Sox2 looping with its distal enhancer.

01-06-2026

European radiology

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

01-06-2026

Cancer research

Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

01-06-2026

Journal of robotic surgery

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

28-05-2026

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

Factors Associated with Healthcare Providers' Lifestyle Information Provision to Adult Patients in Oncology: A Systematic Literature Review.

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Coping with an Uncertain or Poor Cancer Prognosis as an Adolescent or Young Adult: A Cross-Sectional Cluster Analysis.

Stakeholder Perspectives on Potential Open-Label Bias in Patient-Reported Outcome Results From Cancer Clinical Trials: Evidence From the IMPROvE Project.

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysis.

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

Toward a validated European instrument to measure the socioeconomic impact of cancer.

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

Towards robust foundation models for digital pathology.

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Effect of yoga on musculoskeletal complaints in women during endocrine treatment for breast cancer: protocol of the randomised controlled COBRA trial.

Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses.

Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.

Assessing Cardiorespiratory Fitness in Clinical Rehabilitation: Validity of Field Exercise Tests and Patient-Reported Questionnaires.

Patient-reported outcomes in cancer survivorship: insights from two decades of population-based PROFILES registry research.

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

3D intraabdominal molecular imaging of primary prostate cancer, a hybrid approach that utilizes the robotic vision and dexterity.

Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.

Flexible intraoperative detectors for robotic and laparoscopic image-guided surgery: a systematic review.

Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance.

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Actionable Feedback on Signal-to-Background Ratios During Drop-in Radioguided Surgery.

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta1-42-induced neurodegeneration.

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Progress toward personalized management of stage II/III triple negative breast cancer.

Social status impacts T-cell responses through synapse strength in the prefrontal cortex.

Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity.

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

Validating large language model-assisted data extraction from clinical notes.

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

Pervasive and programmed nucleosome distortion on single chromatin fibres.

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Cohesin-mediated loop extrusion and enhancer-associated factors additively contribute to Sox2 looping with its distal enhancer.

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

This site uses cookies

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer's potential against amyloid-beta_1-42-induced neurodegeneration.